Ray Chui, PhD, DSP
Expert in Cardiovascular and Respiratory Data Analytics, Safety Pharmacology, Toxicology, and GLP Compliance
Ray Chui, PhD, DSP
Expert in Cardiovascular and Respiratory Data Analytics, Safety Pharmacology, Toxicology, and GLP Compliance
Professional Summary
With over two decades of experience in cardiovascular and respiratory data analytics, safety pharmacology, and toxicology, Ray specializes in the analysis of hemodynamic, ECG, and respiratory data for both GLP and non-GLP studies. As a co-founder of Cardiovascular Analytics (CVA) with Joel Baublits, he has developed comprehensive data analysis strategies that meet rigorous regulatory standards. Along with his team at CVA, Ray focuses on end-to-end solutions, inclusive of data analysis, interpretation and reporting, for preclinical drug safety and development.
Core Competencies
- Cardiovascular & Respiratory Data Analytics & Interpretation:
Expert in analyzing cardiovascular, respiratory, and hemodynamic data from a wide range of preclinical models, using platforms such as EMKA ecgAUTO and DSI Ponemah. Proficient in interpreting ECG, blood pressure, and respiratory assessments, providing precise insights into study outcomes. - GLP Compliance & Quality Control:
Validated systems and software, in accordance with Nonclinical Laboratory Studies Good Laboratory Practice (GLP) regulations issued by the US Food and Drug Administration (FDA, Title 21, Part 58). - Safety Pharmacology & Toxicology Expertise:
Extensive experience in safety pharmacology and toxicology, providing critical data analysis and interpretation for cardiovascular, respiratory, and toxicology studies. Supports acute and chronic cardiovascular evaluations with robust data insights. - Diligent, Comprehensive, & Timely Reporting:
Delivers fully compliant, comprehensive reports that meet regulatory requirements with industry-leading turnaround times. Known for balancing thoroughness and speed, ensuring clients receive actionable insights without delays.
Personal Philosophy
At the heart of Ray’s work is a genuine passion cardiovascular and safety pharmacology research, and helping clients achieve their development goals. With a deep commitment to collaboration, Ray believes in working closely with partners to ensure every project reflects shared values of diligence, precision, and integrity. His true motivation is not just the analysis itself but how that analysis can drive impactful change, ultimately improving patient outcomes. Ray is proud to co-lead Cardiovascular Analytics with Joel, where their complementary skills allow them to deliver data that matters, with a steadfast focus on scientific rigor and client satisfaction.